Clinical Trial Update: This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating OBI-888 for safe and effective dosing in patients with locally advanced or metastatic solid tumors; the study is terminated with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• OBI-888

Snippet

Sponsor: OBI Pharma, Inc | Conditions: Metastatic Solid Tumors, Locally Advanced Solid Tumors | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-02-22